To map this onto your own calendar, the free tirzepatide titration calculator builds a week-by-week schedule from your starting dose and target dose, with your next step-up date
Safety profile of the proton-pump inhibitors
The synergistic effect of the Contrave combination is well-documented
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), gastroparesis is relatively rare: out of 100,000 people, about 10 men and 40 women are diagnosed with gastroparesis
Only 28% of respondents said it did anything to change how they view GLP-1 medications, the lowest perception-shift score of any commercial in our study
While patients living with chronic life-threatening conditions like Type 2 diabetes may accept these risks, people using GLP-1 drugs for less life-threatening and severe purposes like obesity may be less forgiving if the side effects outweigh the perceived benefits